Prosight Management, LP Albireo Pharma, Inc. Transaction History

Prosight Management, LP

$348 Million
Q1 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$18.01 - $23.78 $81,369 - $107,438	-4,518 Reduced 0.92%	486,726 $10.5 Million
Q3 2022 Nov 14, 2022	BUY	$16.32 - $26.37 $382,687 - $618,350	23,449 Added 5.01%	491,244 $9.51 Million
Q2 2022 Aug 12, 2022	SELL	$18.54 - $37.29 $226,280 - $455,124	-12,205 Reduced 2.54%	467,795 $9.29 Million
Q1 2022 May 16, 2022	SELL	$23.94 - $33.74 $815,923 - $1.15 Million	-34,082 Reduced 6.63%	480,000 $14.3 Million
Q4 2021 Feb 14, 2022	BUY	$21.19 - $31.29 $1.46 Million - $2.16 Million	69,062 Added 15.52%	514,082 $12 Million

Q3 2021 Nov 12, 2021	BUY	$27.36 - $35.98 $4.1 Million - $5.39 Million	149,940 Added 50.81%	445,020 $13.9 Million
Q2 2021 Aug 13, 2021	BUY	$28.9 - $36.87 $3.6 Million - $4.6 Million	124,728 Added 73.22%	295,080 $10.4 Million
Q1 2021 May 14, 2021	SELL	$32.03 - $42.85 $142,181 - $190,211	-4,439 Reduced 2.54%	170,352 $6.01 Million
Q4 2020 Feb 12, 2021	BUY	$31.56 - $42.16 $1.65 Million - $2.2 Million	52,291 Added 42.69%	174,791 $6.56 Million
Q3 2020 Nov 13, 2020	SELL	$23.19 - $41.61 $1.77 Million - $3.17 Million	-76,300 Reduced 38.38%	122,500 $4.09 Million
Q2 2020 Aug 14, 2020	SELL	$14.82 - $29.92 $1.95 Million - $3.94 Million	-131,607 Reduced 39.83%	198,800 $5.27 Million
Q1 2020 May 15, 2020	BUY	$11.67 - $27.23 $971,282 - $2.27 Million	83,229 Added 33.67%	330,407 $5.41 Million
Q4 2019 Feb 14, 2020	SELL	$16.92 - $28.96 $90,048 - $154,125	-5,322 Reduced 2.11%	247,178 $6.28 Million
Q3 2019 Nov 14, 2019	SELL	$20.0 - $31.88 $16,540 - $26,364	-827 Reduced 0.33%	252,500 $5.05 Million
Q2 2019 Aug 14, 2019	SELL	$30.67 - $37.86 $506,331 - $625,030	-16,509 Reduced 6.12%	253,327 $8.17 Million
Q1 2019 May 15, 2019	SELL	$22.22 - $32.21 $6,888 - $9,985	-310 Reduced 0.11%	269,836 $8.69 Million
Q4 2018 Feb 14, 2019	BUY	$20.9 - $32.57 $2.24 Million - $3.49 Million	107,241 Added 65.83%	270,146 $6.63 Million
Q3 2018 Nov 15, 2018	BUY	$29.29 - $36.87 $4.77 Million - $6.01 Million	162,905 New	162,905 $5.37 Million

Others Institutions Holding ALBO

# of Institutions

Shares Held

865

Call Options Held

Put Options Held

View Full List

About ALBIREO PHARMA, INC.

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

More about ALBO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prosight Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Prosight Management, LP with notifications on news.

Account